What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Giorgio Racagni focuses on Internal medicine, Endocrinology, Neuroscience, Neurotrophic factors and Pharmacology.
His study in Endocrinology is interdisciplinary in nature, drawing from both GABAA receptor and Kinase, Cell biology.
His work on Neuroplasticity and Dopaminergic as part of general Neuroscience study is frequently linked to Critical moment and Relevance, therefore connecting diverse disciplines of science.
Giorgio Racagni combines subjects such as CREB, Neurotrophin, Neuroprotection, Prefrontal cortex and Disease with his study of Neurotrophic factors.
Giorgio Racagni has included themes like Brain-derived neurotrophic factor and Hippocampus in his Neurotrophin study.
Giorgio Racagni has researched Pharmacology in several fields, including Clozapine, Antidepressant, Desipramine, Glutamate receptor and Haloperidol.
His most cited work include:
- Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes (426 citations)
- Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus (376 citations)
- Peroxynitrite Inhibits Glutamate Transporter Subtypes (354 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Neuroscience, Pharmacology and Antidepressant.
His research in Endocrinology intersects with topics in Neurotrophic factors, Receptor and Ca2+/calmodulin-dependent protein kinase, Protein kinase A.
His research in Neurotrophic factors tackles topics such as Neurotrophin which are related to areas like Brain-derived neurotrophic factor.
The concepts of his Protein kinase A study are interwoven with issues in Platelet and Signal transduction.
The Neuroscience study which covers Glutamate receptor that intersects with NMDA receptor.
Within one scientific family, he focuses on topics pertaining to Haloperidol under Pharmacology, and may sometimes address concerns connected to Clozapine.
He most often published in these fields:
- Internal medicine (49.30%)
- Endocrinology (48.83%)
- Neuroscience (26.17%)
What were the highlights of his more recent work (between 2011-2021)?
- Neuroscience (26.17%)
- Internal medicine (49.30%)
- Endocrinology (48.83%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Neuroscience, Internal medicine, Endocrinology, Prefrontal cortex and Pharmacology.
His Neuroscience research is multidisciplinary, incorporating perspectives in Brain-derived neurotrophic factor, Neurotrophic factors and Neurotrophin.
His Internal medicine research includes elements of Beck Depression Inventory and Type 2 diabetes.
His Endocrinology study incorporates themes from CREB, MAPK/ERK pathway and Abstinence.
His Prefrontal cortex study combines topics in areas such as Nucleus accumbens, Mesolimbic pathway, Sensitization, Neurochemical and Arc.
His Pharmacology research is multidisciplinary, incorporating elements of Antidepressant, Diabetes mellitus and Anticoagulant.
Between 2011 and 2021, his most popular works were:
- Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity (239 citations)
- Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. (122 citations)
- Current pharmacological treatments for COVID-19: What's next? (85 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
His scientific interests lie mostly in Neuroscience, Neurotrophic factors, Endocrinology, Internal medicine and Pharmacology.
His studies deal with areas such as Brain-derived neurotrophic factor and Neurotrophin as well as Neuroscience.
His Neurotrophic factors research incorporates elements of Serotonin transporter and Serotonergic.
His research in Endocrinology is mostly focused on Glucocorticoid receptor.
His Pharmacology research integrates issues from Antidepressant, Hippocampus and Anticoagulant.
The Agomelatine research Giorgio Racagni does as part of his general Antidepressant study is frequently linked to other disciplines of science, such as Kynurenine pathway, therefore creating a link between diverse domains of science.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
